Aberrant expression of lncRNA ABHD11‐AS1 has been reported to be involved in regulating the development and progression of various tumors, including endometrial carcinoma, bladder cancer, colorectal cancer, and gastric cancer. This evidence concerns the gene ABHD11 and urinary bladder cancer.